Global Cancer News

The coronavirus is affecting us all in many different ways, including our lifestyles and health care routines. A group of Ohio State University researchers will be conducting a survey to see how much COVID-19 has impacted the ability of Ohioans to seek…

A study in mice suggests that by infiltrating tumors and ramping up the body’s immune response, a type of gut bacteria could be a valuable ally in cancer treatment. The authors of the new study note that certain bacteria have also demonstrated…

Source: YaleNews More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a radical idea: What if he could unlock the therapeutic potential of ancient Chinese medicines for treating cancer? What if…

Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study led by Washington University School of Medicine in St. Louis and the Perelman…

One in four cancer patients experienced a delay to their diagnosis that could have been avoided, according to a new study by Cancer Research UK. It found that nearly 3,400 of 14,300 patients experienced a delay that could have been avoided. Half of…

A person’s risk of developing cancer is affected by genetic variations in regions of DNA that don’t code for proteins, previously dismissed as ‘junk DNA’, according to new research published in the British Journal of Cancer. This new study shows that inherited cancer risk…

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with advanced, newly diagnosed ovarian cancer that’s responded to chemotherapy. Olaparib (Lynparza) tablets will be used to help prolong the effects of initial treatment, as a so-called…

The National Institute for Health and Care Excellence (NICE) has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. Trial results have shown that olaparib, which stops cancer cells repairing damage to their DNA, can…

A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatments more quickly in the future, Cancer Research UK scientists have found. As part of the plasmaMATCH clinical trial, funded by Stand Up To Cancer, a joint…

2019 was a year jam packed  with  brilliant progress and  new  challenges for cancer research. Here are some of the top stories of the year:  Re-writing the breast cancer rulebook, A cancer breath test enters trials, three new teams take on some of the biggest challenges in cancer research, tracking cancer evolution with…